Hlif Steingrimsdottir
Reykjavik, Iceland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Impact of SARS-CoV-2 vaccination on monoclonal gammopathy of undetermined significance: results from the population-based iStopMM study.
Journal: Blood cancer journal
Published: October 08, 2025
Association Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance : An Analysis From a Population-Based Screening Study.
Journal: Annals of internal medicine
Published: May 20, 2024
Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined Significance : A Cohort Study Nested in a Clinical Trial.
Journal: Annals of internal medicine
Published: April 01, 2024
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study.
Journal: Blood cancer journal
Published: June 20, 2022
Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study.
Journal: Blood cancer journal
Published: September 03, 2021
Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies.
Journal: Blood cancer journal
Published: December 09, 2020
Chronic lymphocytic leukemia in Iceland from 2003 to 2013: Incidence, presentation and diagnosis
Journal: Laeknabladid
Published: May 20, 2016
Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.
Journal: Nature communications
Published: December 18, 2014
Last Updated: 09/26/2026